Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
EditorialEditor’s Page

Is This Whom We Have Become?

Johannes Czernin
Journal of Nuclear Medicine August 2018, 59 (8) 1171;
Johannes Czernin
David Geffen School of Medicine at UCLA, Los Angeles, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading
Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Johannes Czernin

During the June 2018 annual meeting of the Society of Nuclear Medicine and Molecular Imaging, the authors of the best articles of 2017 were honored. The best basic science award went to Dr. Fabien Hyafil for his article entitled “Imaging the Cytokine Receptor CXCR4 in Atherosclerotic Plaques with the Radiotracer 68Ga-Pentixafor for PET” (1). Dr. Martin Grootendorst was awarded the best translational science manuscript for “Intraoperative Assessment of Tumor Resection Margins in Breast-Conserving Surgery Using 18F-FDG Cerenkov Luminescence Imaging: A First-in-Human Feasibility Study” (2).

The 2018 award for best clinical and best overall manuscript of 2017 went to an outstanding group of clinician scientists for their article “German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients” (3).

The first 2 authors of this paper had enthusiastically agreed to accept the award in person, but only Dr. Kambiz Rahbar was present during the ceremony. Dr. Hojjat Ahmadzadehfar, the second author of the article, mailed the following letter and gave his permission to publish it.

Dear Prof. Czernin,

Unfortunately, I cannot attend the congress this year and therefore I cannot attend the award ceremony. The reason for this is that I did not get a visa for entry. Since I have a dual nationality (Iranian and German), I have to apply for a visa under US regulations. I did that on March 14. Although you usually get feedback within a few weeks (max 6 weeks), I have not received a visa yet. I have repeatedly asked the US embassy about my visa, each time they wrote me that my case is still being processed. They have not returned to me even my passport.

My good friend Prof. Kambiz Rahbar is there for the award and he will also represent me.

I apologize for the circumstances, but it is beyond my power.

With best regards,

Hojjat

Prof. Dr. med. Hojjat Ahmadzadehfar, MSc

Head of the therapy section

University Hospital Bonn

Dear Dr. Ahmadzadehfar,

You apologize for the circumstances. It is, of course, we who have to apologize.

I would hope that common sense, respect, normal human behavior and decency will be reintroduced in the foreseeable future.

Sincerely and Congratulations to winning the best manuscript award,

Johannes Czernin

  • © 2018 by the Society of Nuclear Medicine and Molecular Imaging.

REFERENCES

  1. 1.↵
    1. Hyafil F,
    2. Pelisek J,
    3. Laitinen I,
    4. et al
    . Imaging the cytokine receptor CXCR4 in atherosclerotic plaques with the radiotracer 68Ga-pentixafor for PET. J Nucl Med. 2017;58:499–506.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Grootendorst MR,
    2. Cariati M,
    3. Pinder SE,
    4. et al
    . Intraoperative assessment of tumor resection margins in breast-conserving surgery using 18F-FDG Cerenkov luminescence imaging: a first-in-human feasibility study. J Nucl Med. 2017;58:891–898.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Rahbar K,
    2. Ahmadzadehfar H,
    3. Kratochwil C,
    4. et al
    . German multicenter study investigating 177Lu-PSMA-617 radioligand therapy in advanced prostate cancer patients. J Nucl Med. 2017;58:85–90.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 59 (8)
Journal of Nuclear Medicine
Vol. 59, Issue 8
August 1, 2018
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Is This Whom We Have Become?
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Is This Whom We Have Become?
Johannes Czernin
Journal of Nuclear Medicine Aug 2018, 59 (8) 1171;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Is This Whom We Have Become?
Johannes Czernin
Journal of Nuclear Medicine Aug 2018, 59 (8) 1171;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Reflections on the Demand for PSMA- and SSTR-Targeted Radiopharmaceutical Therapies: Why We Were Wrong (and Why We Will Be Right Eventually)
  • The Costs to Our Patients
  • Is ChatGPT a Reliable Ghostwriter?
Show more Editor’s Page

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire